Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9VCS

Cryo-EM structure of semi-closed state of Botulinum neurotoxin serotype A at pH 7.4

Summary for 9VCS
Entry DOI10.2210/pdb9vcs/pdb
Related9GKQ
EMDB information51433 64966
DescriptorBotulinum neurotoxin type A (1 entity in total)
Functional Keywordsbotulinum neurotoxin serotype a, cryo-em, toxin
Biological sourceClostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A)
Total number of polymer chains1
Total formula weight151022.52
Authors
Zerang, Z.,Liu, Z.,He, J.,Wang, X.,Qi, F.,Lei, D.,Zhi, D.,Wang, D. (deposition date: 2025-06-06, release date: 2026-04-22)
Primary citationWang, W.,Zerang, Z.,You, L.,Liu, Z.,Nie, R.,Qi, F.,Gao, F.,Zhao, C.,Ma, W.,He, J.,Wang, X.,Wu, S.,Liu, B.,Liu, X.,Lei, D.,Zhi, D.,Wang, D.
Cryo-EM Structure Guided Engineering of Botulinum Neurotoxin A With Advanced Receptor Binding Affinity and Therapeutical Benefits.
Adv Sci, :e16713-e16713, 2026
Cited by
PubMed Abstract: Botulinum neurotoxin type A (BoNT/A) has been extensively used in treating a wide range of neurological disorders and aesthetics. However, insufficient binding affinity between BoNT/A and its receptor SV2C could lead to mild to severe side effects. An open active conformation of BoNT/A cryo-EM structure at a resolution of ∼2.85 Å was resolved. Guided by the BoNT/A cryo-EM structure, saturation mutagenesis libraries were constructed and screened by BACTH system to identify mutants that can boost toxin-SV2C affinity. The engineered toxin binding domain achieved up to approximately six-fold improved affinity in SPR analysis, and the engineered toxins exhibited significantly improved binding capacity, and enhanced SNAP25 cleavage efficacy in cultured neurons. Preclinical animal studies, including MLB, DAS, sweat test, and PET/CT assays, demonstrated that the engineered BoNT/A VLTS has higher potency, lower diffusion, and significantly better safety profiles than the BoNT/A wt, which can reduce side effects and benefit future therapeutic applications.
PubMed: 41944347
DOI: 10.1002/advs.202516713
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.8 Å)
Structure validation

254587

PDB entries from 2026-06-03

PDB statisticsPDBj update infoContact PDBjnumon